Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Cordoba-Rodriguez

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
PDA Journal of Pharmaceutical Science and Technology|April 20, 2011
Raw materials in the manufacture of biotechnology products: regulatory considerationsRuth Cordoba-Rodriguez
Expert Opinion on Biological Therapy|July 26, 2003
IL-23 and IL-27: new members of the growing family of IL-12-related cytokines with important implications for therapeuticsRuth Cordoba-Rodriguez, David M Frucht
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2005
Anthrax lethal toxin blocks MAPK kinase-dependent IL-2 production in CD4+ T cellsHui Fang, Ruth Cordoba-Rodriguez, Carla S R Lankford, et al.
The Journal of Biological Chemistry|March 11, 2004
Anthrax lethal toxin rapidly activates caspase-1/ICE and induces extracellular release of interleukin (IL)-1beta and IL-18Ruth Cordoba-Rodriguez, Hui Fang, Carla S R Lankford, et al.
Journal of Pharmaceutical Sciences|February 16, 2023
Protein Aggregates in Inhaled Biologics: Challenges and ConsiderationsMariam Ibrahim, Ian Wallace, Saba Ghazvini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
U.S. Food and Drug Administration approval: panitumumab for epidermal growth factor receptor-expressing metastatic colorectal carcinoma with progression following fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimensRuthann M Giusti, Kaushikkumar Shastri, Anne M Pilaro, et al.
Journal of Pharmaceutical Sciences|February 19, 2024
Patient-centric Comparability Assessment of BiopharmaceuticalsMarkus Blümel, Ruth Cordoba-Rodriguez, James A Carroll, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
PDA Journal of Pharmaceutical Science and Technology|April 20, 2011
Raw materials in the manufacture of biotechnology products: regulatory considerationsRuth Cordoba-Rodriguez
Expert Opinion on Biological Therapy|July 26, 2003
IL-23 and IL-27: new members of the growing family of IL-12-related cytokines with important implications for therapeuticsRuth Cordoba-Rodriguez, David M Frucht
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2005
Anthrax lethal toxin blocks MAPK kinase-dependent IL-2 production in CD4+ T cellsHui Fang, Ruth Cordoba-Rodriguez, Carla S R Lankford, et al.
The Journal of Biological Chemistry|March 11, 2004
Anthrax lethal toxin rapidly activates caspase-1/ICE and induces extracellular release of interleukin (IL)-1beta and IL-18Ruth Cordoba-Rodriguez, Hui Fang, Carla S R Lankford, et al.
Journal of Pharmaceutical Sciences|February 16, 2023
Protein Aggregates in Inhaled Biologics: Challenges and ConsiderationsMariam Ibrahim, Ian Wallace, Saba Ghazvini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
U.S. Food and Drug Administration approval: panitumumab for epidermal growth factor receptor-expressing metastatic colorectal carcinoma with progression following fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimensRuthann M Giusti, Kaushikkumar Shastri, Anne M Pilaro, et al.
Journal of Pharmaceutical Sciences|February 19, 2024
Patient-centric Comparability Assessment of BiopharmaceuticalsMarkus Blümel, Ruth Cordoba-Rodriguez, James A Carroll, et al.
Pageof 1